pentaxcoin
Injective Protocol Launches Mainnet, $120M Incentive Program

Injective Protocol Launches Mainnet, $120M Incentive Program

Key Takeaways

Decentralized derivatives exchange Injective Protocol has announced launch of its mainnet.
To accompany the mainnet launch, Injective is also releasing a $120 million program to incentivize liquidity provisioning and trading.
The program will allocate the funds to market makers and traders who utilize the protocol based on their activity.

Share this article

Injective, a cross-chain DeFi protocol for derivatives trading, has announced the public launch of its mainnet today. It’s also rolling out a $120 million liquidity incentive program for traders, market makers, and DeFi projects. 
Derivatives Trading Protocol Injective Heads to Mainnet
Injective Labs has announced the mainnet launch of its derivatives exchange. 
Injective Protocol is a Layer 2, cross-chain protocol for decentralized derivatives trading. It’s built on top of the Tendermint consensus engine using Cosmos-SDK. The Injective decentralized exchange lets users permissionlessly create and trade spot and derivatives crypto instruments across different chains with zero fees and instant transaction finality.
Injective Labs claims that the exchange is fully decentralized. It’s also built to be fully trustless, censorship-resistant, transparent, and interoperable while providing a comparable user experience to that found on centralized exchanges.
In a press release, Injective Labs co-founder and CEO Eric Chen said of the launch:
“Our mission at Injective has always been to build the most powerful cross-chain protocol for completely decentralized derivatives trading. As Injective interconnects new chains, the ecosystem will continue to serve as a DeFi gateway for trading across the multi-chain universe. Injective’s Ethereum-native tooling allows users to simply create and trade new cross-chain markets without the typical roadblocks associated with making transactions across distinct blockchain networks.”
To accompany the mainnet launch and promote liquidity provisioning and trading on the protocol, the team has also announced the launch of a $120 million protocol incentive program named Astro. It’s the largest incentive program to date within the Cosmos ecosystem. According to the announcement, the program will allocate the funds to market makers and traders who utilize the protocol based on the volume of their activity.

The launch comes during a busy year for Injective Labs. In April, the firm raised $10 million at a $1 billion valuation from some of crypto’s most well-known venture capital firms, including Pantera Capital, BlockTower, Hashed, Cadenza ventures, and CMS. Shark Tank host and Dallas Mavericks owner Mark Cuban also backed the project. Injective’s decentralized exchange has also seen significant adoption, counting over $1 billion in average daily trading volume across 25,000 unique monthly users. Besides exotic financial instruments, the protocol has also added support for commodities, forex, and synthetic stocks trading in 2021.

Share this article

The information on or accessed through this website is obtained from independent sources we believe to be accurate and reliable, but Decentral Media, Inc. makes no representation or warranty as to the timeliness, completeness, or accuracy of any information on or accessed through this website. Decentral Media, Inc. is not an investment advisor. We do not give personalized investment advice or other financial advice. The information on this website is subject to change without notice. Some or all of the information on this website may become outdated, or it may be or become incomplete or inaccurate. We may, but are not obligated to, update any outdated, incomplete, or inaccurate information.
You should never make an investment decision on an ICO, IEO, or other investment based on the information on this website, and you should never interpret or otherwise rely on any of the information on this website as investment advice. We strongly recommend that you consult a licensed investment advisor or other qualified financial professional if you are seeking investment advice on an ICO, IEO, or other investment. We do not accept compensation in any form for analyzing or reporting on any ICO, IEO, cryptocurrency, currency, tokenized sales, securities, or commodities.
See full terms and conditions.

DeFi Project Spotlight: Injective Protocol, a Derivatives DEX

Injective Protocol is a decentralized derivatives project that offers fast transaction speeds, deep liquidity, and front-running protection. The project makes up part of the growing DeFi ecosystem that is being…

Injective Raises $10 Million for Robinhood Alternative

Decentralized derivatives trading platform Injective Protocol has raised $10 million in its latest round of funding. Injective Raises $10 Million Injective Protocol has raised $10 million from some of crypto’s…

A Guide to Yield Farming, Staking, and Liquidity Mining

Yield farming is arguably the most popular way to earn a return on crypto assets. Essentially, you can earn passive income by depositing crypto into a liquidity pool. You can think of these liquidity…

After FAANG Stocks, Injective Protocol Lists GameStop

Decentralized exchange (DEX) Injective Protocol has rolled out the first decentralized and commission-free futures trading of GameStop (GME) stock. Injective Competes With US Brokerages  Injective has listed GME futures trading…

Frances Jones

Frances Jones

Frances is a Senior Forex, Cryptocurrencies, and Financial Market Strategist with a background in IT and financial markets. He specializes in market strategies and technical analysis and has spent over a DECADE as a financial markets contributor and observer. He possesses strong technical analytical skills and is well known for his entertaining and informative analysis of the currency, commodities, Bitcoin, and Ethereum markets.